Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/Industry Manufacturing Approach Is “Suboptimal” – CDER’s Woodcock

This article was originally published in The Tan Sheet

Executive Summary

FDA is ready to change the current model of manufacturing oversight and enforcement, Center for Drug Evaluation & Research Director Janet Woodcock, MD, indicated during the recent Lehman Brothers Global Healthcare Conference in Orlando
Advertisement

Related Content

Drug Industry CEOs Are Taking “Positive” Steps On GMPs, FDA’s Galson Says
Drug Industry CEOs Are Taking “Positive” Steps On GMPs, FDA’s Galson Says
Drug Industry CEOs Are Taking “Positive” Steps On GMPs, FDA’s Galson Says
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
PAT Plus Three-Batch Validation Suggested As Transition Approach By FDA
HHS Puts Stamp On FDA: Crawford Named Acting Commissioner

Topics

Advertisement
UsernamePublicRestriction

Register

PS093754

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel